Two individuals in Pennsylvania have died from measles, marking the first reported deaths attributed to the disease in the U.S. this year. This development coincides with a significant increase in measles cases nationwide, with over 2,700 cases reported so far this year. This figure represents the highest number of cases since measles was largely eliminated in the country in 2000, and more cases have occurred in the past two years than in the preceding 24 years combined.
Meadows is a highly contagious viral illness characterized by symptoms such as high fever, cough, and a distinctive rash. While some individuals experience mild illness, approximately one in four infected people require hospitalization. Those at higher risk for severe complications include young children, pregnant women, and the elderly. Currently, no specific antiviral treatment exists for measles.
The measles vaccine, administered as part of the measles, mumps, and rubella (MMR) combination shot, is highly effective, providing a 97% protection rate. It also reduces the likelihood of severe complications if an infection does occur.
"Because measles was largely eliminated in the [state] for more than three decades, people are not familiar with this disease and don’t fully understand the potential severity of the illness," stated Dr. Debra Bogen, Pennsylvania’s health secretary, highlighting a potential disconnect between the public's understanding of the disease and its risks.